chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling and pain of lymph nodes in left axilla; Chills; lowgrade fever occurring 18 to 30 hours after 2nd dose; This is a spontaneous report from a contactable physician (patient). A 68-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an intramuscular route on 21Feb2021 14:30 (at the age of 68-years) as dose 2, single in the left arm for covid-19 immunisation. The patient medical history included hypothyroidism and Known allergies to Sulfa, PCN, verapamil. The patient concomitant medications included levothyroxine sodium (SYNTHROID) for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 24Jan2021 14:30 (at the age of 68-years) as dose 1, single in the left arm for covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Feb2021 at 13:00, the patient experienced chills and low grade fever occurring 18 to 30 hours after 2nd dose and swelling and pain of lymph nodes in left axilla. The patient did not receive treatment for events. The outcome of the events was resolved on unspecified date of 2021.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
"throwing up non-stop"; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING PROJECTILE ("throwing up non-stop") in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN for Cholesterol, ATENOLOL for Hypertension.    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced VOMITING PROJECTILE ("throwing up non-stop"). The patient was treated with ONDANSETRON (ZOFRAN [ONDANSETRON]) at a dose of unknown. At the time of the report, VOMITING PROJECTILE ("throwing up non-stop") outcome was unknown.            Treatment ZOFRAN   This case was linked to MOD-2021-078029 (E2B Linked Report).; Sender's Comments:  MOD-2021-078029:First dose case
Information has been downloaded from regulatory authority (HQ5628306SEP2001). This spontaneous report was received from a health professional and refers to a 21 month old male patient. The patient's concurrent conditions and concomitant therapies were not reported. The patient's medical history included unspecified ear infection. On 23-APR-2001, the patient was vaccinated with the first dose of VARIVAX, 1 dosage form, subcutaneously, lot # 636578/1471K, expiration date 28-SEP-2002 for immunization, the first dose of M-M-R II 1 dosage form, subcutaneously, lot # reported as 1274K (expiration date was not reported) for immunization, the first dose of PREVNAR 1 dosage form, intramuscularly, batch/lot number 475-382 (expiration date was not reported) for immunization, the first dose of poliovirus vaccine inactivated (unspecified) 1 dosage form (route of administration, lot # and expiration date were not reported) for immunization, the first dose of hib conj vaccine (unspecified carrier) injection, 1 dosage form once daily (qd), intramuscularly, batch/lot number 474-714 (expiration date was not reported) for immunization, and the first dose of INFANRIX 1 dosage form qd, intramuscularly, batch/lot number 970A2 (expiration date was not reported) for immunization. On 28-JUN-2001, the patient experienced acute cerebellar ataxia, crying, vomiting, fever and sinus infection. The outcome of all events was unknown. The relatedness between the events and suspect therapies was not reported. The reporter considered all events to be medically significant. Lot number # 1274K is an invalid lot number for measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live.
Patient had syncope ~ 10 min after receiving the vaccine. At the same time was watching her sibling having blood drawn.
eyes is is blood shot red eye; A spontaneous report was received from a consumer concerning a Drug Start Date-1956-1-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events eyes is is blood shot red eye.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On , prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: ) via unknown route for prophylaxis of COVID-19 infection. On 22 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On 22 Feb 2021, the patient experienced the event(s) eyes is is blood shot red eye.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), eyes is is blood shot red eye was unknown.
drastic spike in my blood pressure/It has always been a little up but not this bad top number was 229; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of BLOOD PRESSURE INCREASED (drastic spike in my blood pressure/It has always been a little up but not this bad top number was 229) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (drastic spike in my blood pressure/It has always been a little up but not this bad top number was 229). At the time of the report, BLOOD PRESSURE INCREASED (drastic spike in my blood pressure/It has always been a little up but not this bad top number was 229) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
This is a non serious spontaneous case from a physician in the USA who reports a patient tested positive for influenza A (Labeled,USA). The reporter did not provide causality between events and FluMist vaccination. On Nov 11 2004, a 6 year old male received FluMist intranasally and developed fever, sore throat, and stomach ache on the morning of Mar 19 2005. He went to an urgent care facility where he initiated amoxicillin treatment. On Mar 21 2005, the patient visited the doctor where he complained of fever, runny nose, and red eyes. A nasal swab was taken and tested for Influenza A and B. The patient tested positive for influenza A and he discontinued amoxicillin. The patient has improved but has not yet recovered.
I'm not as well on this as before. the effects it has on the human body.; This is a spontaneous report from a contactable consumer (patient).   A 73-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot number, Expiration date were not provided), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation and palbociclib (IBRANCE), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 100 mg for an unspecified indication. The patient's medical history and Concomitant medication were not reported. The patient stated "I'm not as well on this as before. I'm not sure if it's the COVID shot and the effects it has on the human body." The outcome of the event was Unknown.   The lot number for the vaccine was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101034137
Diagnosed with cellulitis in arm of injection; Raised area 5 in X 4 in at site of injection; Redness at site of injection; nduration at site of injection; Redness spread to upper arm and antecubital site of injected arm; Site of injection is cherry red; Itchiness at site of injection; Tenderness at site of injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE INDURATION (nduration at site of injection), INJECTION SITE MASS (Raised area 5 in X 4 in at site of injection), ERYTHEMA (Redness spread to upper arm and antecubital site of injected arm) and INJECTION SITE DISCOLOURATION (Site of injection is cherry red) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE INDURATION (nduration at site of injection), INJECTION SITE MASS (Raised area 5 in X 4 in at site of injection), ERYTHEMA (Redness spread to upper arm and antecubital site of injected arm), INJECTION SITE DISCOLOURATION (Site of injection is cherry red), INJECTION SITE PRURITUS (Itchiness at site of injection) and INJECTION SITE PAIN (Tenderness at site of injection). On 24-Feb-2021, the patient experienced INJECTION SITE CELLULITIS (Diagnosed with cellulitis in arm of injection). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) on 23-Feb-2021 at a dose of UNK dosage form and DOXYCYCLINE on 24-Feb-2021 at a dose of UNK dosage form. At the time of the report, INJECTION SITE ERYTHEMA (Redness at site of injection), INJECTION SITE INDURATION (nduration at site of injection), INJECTION SITE MASS (Raised area 5 in X 4 in at site of injection), ERYTHEMA (Redness spread to upper arm and antecubital site of injected arm), INJECTION SITE DISCOLOURATION (Site of injection is cherry red), INJECTION SITE PRURITUS (Itchiness at site of injection), INJECTION SITE PAIN (Tenderness at site of injection) and INJECTION SITE CELLULITIS (Diagnosed with cellulitis in arm of injection) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
After receiving both vaccines on 10/25/23, during the 15min. observation time around 10:19am she was slouched down in the chair and I went over to her.  She was able to communicate and said her hands were tingling and felt numb and she was breathing heavy.  She said the Covid vaccine hurt a little bit going in.  She gave me her mom and fathers phone number but we got answering machines for both. She said she felt funny.  The assistant store manager was called and she spoke to the patient.  She said she felt nauseous and EMT was contacted around 10:35am and when they arrived they took her vitals gave she was given water.  She declined leaving with EMT and they left the pharmacy around 10:50am.  Her father came and took her home at 11:24am.
Pt received immunizations x4 Thursday. This am father noted significant inflammation warmth & redness to left deltoid. Seen in office given BENADRYL & antibiotic on Saturday.
Aches, pains all over body.  Progressed to severe headache, neck pain.  No weakness, no blurry vision. No fever. Diagnosed with aseptic meningitis.
Nausea, headache, stiff neck six hours later.  Muscle pain, elevated  blood pressure, severe ringing in ears  occurred 15 hours (3am) after injection. Saw PCP on 3/25- prescribed blood pressure medication (never taken before) and referred to ENT. Saw ENT  on 3/29 and 3/30.  Prescribed high dose Prednisone for two weeks.  Hearing test shows hearing loss in left ear. Received injection in left arm.  Shrill high pitched  ringing in both ears with no improvement.  See Audiologist on 4/20 for hearing recheck to see if hearing has improved in left ear.
Heart palpitations  starting 3 days after vaccine. Off and on until Sunday November 13th.   Suffered a stroke on the 13th. Admitted to local Hospital on the 14th. MRI showed  Stroke.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On an unspecified date in September 2012, the patient was vaccinated with the first dose of GARDASIL (dose, route and lot # not reported). On 29-MAR-2013, the patient received the second dose of GARDASIL (dose, route and lot # not reported) and on 02-MAY-2013, the patient received the third dose of GARDASIL (dose, route and lot # not reported). No adverse effects were reported. Additional information has been requested.
pts mother stated that about 45 minutes after the vaccine the patient developed a sore throat.  She started feeling sleepy, and not feeling well.  She had to body aches and was extremely weak.  The next morning her chest was hurting like something was sitting on it.  She was coughing, had stuffy nose, loss of appetite, and very fatigued.  She went to clinic.  She had US and EKG with negative results.  She was diagnosed Costochondritis.  She was given medicine for nausea, told to use Ibuprofen and to FU w/ Primacy care doctor.  She slept for almost 3 days.  She continues to have a cough.
02/8/2005- Rash and Fever. 02/11/2005- Fever, then infebrile seizure lasting 1 minute. Seen in office with lesions on neck behing ears, scalp, trunk, and arms.
Acute CHF with LV thrombus, multiple strokes involving MCA and left cerebellar stroke, aphasia, left-sided paralysis, immobility. Patient was given tPA, clinical symptoms still progressed. In rehab facility now.
pt c/o of rt. hand pain after the vaccine,  numbness of both hand.  chest tightness after 10 mins of vaccination.  the symptoms were resolved and patient went home.
pt admitted to hosp with increasing SOB, cough, diarrhea and nausea; placed on O2 via NC; DNR/DNI; dexamethasone; increasing O2 requirements; placed on BiPAP; sx continued to increase and pt was placed on comfort care; O2 was removed and pt was given Haldol and Morphine for agitation and dyspnea; pt died in the hosp
Go to sleep with no issue unlike the first dose; post-vaccine swelling; post-vaccine pain; post-vaccine redness; This case was reported by a other health professional via call center representative and described the occurrence of sleep disorder in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sleep disorder, swelling, pain and erythema. On an unknown date, the outcome of the sleep disorder, swelling, pain and erythema were unknown.   It was unknown if the reporter considered the sleep disorder, swelling, pain and erythema to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced post-vaccine swelling, pain, redness and she could not go to sleep without problems.  Upon follow up with the patient, the patient stated she did not experience any adverse reaction to the 2nd Shingrix vaccine. The patient called to request information for vaccine stability after a warm compress was used to manage pain at site of injection. This was the 2nd dose and the use of heat helped a lot in the management of the pain as per reporter. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021010498:same patient
Information was received from a registered nurse concerning an unspecified 21 year old patient (gender unknown). No information was provided regarding the patient's past medical history, concurrent conditions or concomitant medication. On 19-OCT-2009, the patient was vaccinated with a first dose of GARDASIL (reported as "GARDASIL 4") (lot number, expiration date, dosage and route of administration not provided). On 18-MAY-2010, the patient received a second dose of GARDASIL (reported as "GARDASIL 4") (lot number, expiration date, dosage and route of administration not provided). On the same day, 18-MAY-2010, the patient also received a "third dose" of CERVARIX (lot number, expiration date, dosage and route of administration not provided). No adverse effect reported. No further information was provided. Additional information has been requested.
Bells Palsy - facial droop left side. Occurred 18 hours after shot.
Within a few hours of the vaccination and following the vaccination, I began experiencing muscle aches throughout my body, fatigue, fever (over 100.2 F), chills, sweating, and felt a lot of aching pain in my back. The following day I got my period, as I should have, and had the most period cramping pain I have experienced, not permitting me to continue with a normal day. Since the vaccination, my period has become heavier, longer cycles, and worse cramps than before.
I started feeling symptoms on 11/09/2022. I had a cough; sore throat and nasal congestion.
little bit of diarrhea; chill; little bit of nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (little bit of diarrhea), CHILLS (chill) and NAUSEA (little bit of nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (little bit of diarrhea), CHILLS (chill) and NAUSEA (little bit of nausea). At the time of the report, DIARRHOEA (little bit of diarrhea), CHILLS (chill) and NAUSEA (little bit of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Patient stated when woke up the next day had a rash around the injection site and on both knees ( front and back area of the knees). Patient stated took bendryl.
Symptom onset 02/25/2022, myalgia, sore throat, cough, dyspnea, hospitalization date 02/27/2022
Low grade fever and lethargic for six days now.  Only 35 lbs and wished patient had shot vice mist.  Going back to doctor on 10/17/2011.
12 mo male received flu shot yesterday returns today with rash on knees, elbows, torso and face maculopapular with erythema - no hives. Does not appear viral most likely reaction to  to immunization
Non-ST elevation (NSTEMI) myocardial infarction; Acute kidney failure, unspecified; Pneumonia, unspecified organism
Patient experienced light-headedness immediately after receiving vaccination. Patient bleed slightly and while I applied pressure and then a bandaid the patient started to feel weak. I had hear sit in a chair inside the pharmacy and prop her legs. In a couple minutes the patient turned very white and and slumped over in the chair. For a minute she did not respond to myself or her sister talking to her and asking her questions. Within another minute the patient started talking and responding normally. I called EMS and they came within minutes to check her vitals. Her blood pressure was lower than her normal. Her blood sugar was normal. The EMT considered her to have experience vasovagal syncope.
Anxiety; hands shaking; feeling of weightlessness/feeling of floating; Invalid dose of 1ml of Moderna Vaccine; This spontaneous case was reported by a nurse and describes the occurrence of ANXIETY (Anxiety), TREMOR (hands shaking), FEELING ABNORMAL (feeling of weightlessness/feeling of floating) and ACCIDENTAL OVERDOSE (Invalid dose of 1ml of Moderna Vaccine) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Sulfonamide allergy.    On 06-Apr-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced ANXIETY (Anxiety), TREMOR (hands shaking) and FEELING ABNORMAL (feeling of weightlessness/feeling of floating). 06-Apr-2021, the patient experienced ACCIDENTAL OVERDOSE (Invalid dose of 1ml of Moderna Vaccine). On 06-Apr-2021, ACCIDENTAL OVERDOSE (Invalid dose of 1ml of Moderna Vaccine) had resolved. On 10-Apr-2021, ANXIETY (Anxiety), TREMOR (hands shaking) and FEELING ABNORMAL (feeling of weightlessness/feeling of floating) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not  provided.   This case was linked to MOD21-071039, MOD21-071001, MOD21-070955, MOD21-071038, MOD21-071043, MOD21-071046, MOD21-071048 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: On 26-MAY-2021 a follow up was received, Patient demographics was updated. Batch number of suspect product details was added. Allergic conditions were added. New events were added. Event's start, stop dates and outcome was added. On 22-Jul-2021: A significant follow up was received on 22-JUL-2021 where outcome of the events were updated.; Sender's Comments: This report refers to a case of Accidental overdose, for mRNA-1273, lot # 044A21A,  with no associated AEs. MOD21-071039: MOD21-071001: MOD21-070955: MOD21-071038: MOD21-071043: MOD21-071046: MOD21-071048:
This is a spontaneous report from a contactable pharmacist. A 67-year-old female patient of unspecified race/ethnicity received PREVNAR 13 ((Lot# Q02071, Exp date 31Jan2018, NDC 00005197102, UPC 300051971022), via an unspecified route of administration, on 15Jun2017, at single dose, for immunisation and LIPITOR film-coated tablet, via an unspecified route of administration, from/to an unspecified date, at an unspecified posology, for an unspecified indication. Relevant medical history included diabetic. Concomitant medications included VICTOZA for diabetes mellitus, metformin (unspecified trade name) for diabetes mellitus, GLUCOTROL for diabetes mellitus and TYLENOL for knee pain. The patient experienced severe headache on 26Jun2017 with outcome of not recovered, eyes burn on 26Jun2017 with outcome of unknown, arm muscle pain on 26Jun2017 with outcome of recovering, soreness of the site of injection on 26Jun2017 with outcome of recovering, soreness on 26Jun2017 with outcome of unknown.